Invention Grant
- Patent Title: Methods of treating cancers with CT45 targeted therapies
-
Application No.: US16300267Application Date: 2017-05-11
-
Publication No.: US11261223B2Publication Date: 2022-03-01
- Inventor: Ernst Lengyel , Matthias Mann , Marion Curtis , Fabian Coscia
- Applicant: The University of Chicago , Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
- Applicant Address: US IL Chicago; DE Munich
- Assignee: The University of Chicago,Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
- Current Assignee: The University of Chicago,Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
- Current Assignee Address: US IL Chicago; DE Munich
- Agency: Norton Rose Fulbright US LLP
- International Application: PCT/IB2017/052781 WO 20170511
- International Announcement: WO2017/195153 WO 20171116
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K45/06 ; A61K35/17 ; C07K14/725 ; A61K31/337 ; A61P35/00 ; A61K33/243 ; A61K38/17 ; A61K38/20 ; A61K39/395 ; C07K16/30 ; C12N5/0783 ; C12Q1/6886 ; G01N33/574 ; A61K39/00 ; A61K31/555 ; A61K31/706
Abstract:
The current disclosure relates to methods for treating ovarian cancer based on specific antigen expression of the cancer. Furthermore, the expressed antigen may be used in immunotherapeutic methods for treatment of the ovarian cancer. Aspects of the disclosure relate to immunotherapies targeting CT45 polypeptides, methods for treating ovarian cancer based on CT45 expression, and kits for detecting CT45 polypeptides and nucleotides.
Public/Granted literature
- US20190144516A1 METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES Public/Granted day:2019-05-16
Information query
